Company Overview of Nuron Biotech Inc.
Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.
1 East Uwchlan Avenue
Exton, PA 19341
Founded in 2010
Key Executives for Nuron Biotech Inc.
Nuron Biotech Inc. Key Developments
Similar Private Companies By Industry
|NantBioscience, Inc.||United States|
|Infusion Specialties Inc.||United States|
|Invenra Inc.||United States|
|ALCiS Health, Inc.||United States|
|Apertus Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
January 31, 2014
To contact Nuron Biotech Inc., please visit www.nuronbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.